Laboratory Network

Blog
The landscape of the life sciences industry is as vast and varied as the professionals who work in it. Some online resources aim to serve the entire space. We wish them luck. Instead, our goal is to be the most valuable resource for a specific segment of the industry – laboratory chemicals, systems, services and equipment – and the professionals who make their living there. The Laboratory Network community is not made up of generalists. Source

Actions

Share this page

Media Outlet details

Scope Trade/B2B
Language English
Country United States of America
Similarweb UVMSimilarweb UVM Request pricing
Comscore UVMComscore UVM Request pricing

Recent Articles

Search

Tribun Health Announces CaloPix 6, Its First IVDR-Certified Version For Routine Diagnostic Use

| Laboratory Network
A major new milestone in the digital transformation of pathology, benefiting laboratories, clinicians, and patients. Following FDA clearance in 2025, CaloPix’s IVDR certification confirms Tribun Health’s ability to serve the global digital pathology market.
Open in Who Shared View Duplicates (67) Issue with article?

Allarity Therapeutics Announces The Grant Of Essential U.S. Patent For Its Stenoparib DRP® Companion Diagnostic

| Laboratory Network
Key U.S. patent now protects exclusivity for developing stenoparib with the stenoparib-DRP® until April 2042 Tarpon Springs, FL (GLOBE NEWSWIRE) - Allarity Therapeutics, Inc.
Open in Who Shared View Duplicates (78) Issue with article?

InterVenn Biosciences And Aranscia Expand Commercialization Partnership For GlycoKnow™ Ovarian Cancer Diagnostic Test

| Laboratory Network
Aranscia's Technology Platform to Accelerate InterVenn's Research and Commercialization Initiatives South San Francisco, CA.
Open in Who Shared View Duplicates (47) Issue with article?

IntelliGenome Receives INVIMA Approval For CRISPR-TB Blood Test And Appoints Velez Lab As Exclusive Distribution Partner In Colombia

| Laboratory Network
Houston, TX and Bogotá, Colombia /PRNewswire/ - IntelliGenome, Inc., a molecular diagnostics company advancing next-generation tuberculosis detection technologies, today announced that Colombia's National Institute for Food and Drug Surveillance (INVIMA) has granted sanitary registration for the CRISPR-TB Blood Test Kit, enabling commercialization of the test in Colombia.
Open in Who Shared View Duplicates (2) Issue with article?

Ultra-High Precision Optical Flats

| Laboratory Network
Optical Surfaces Ltd. is a leading supplier of ultra-high precision optical flats to research establishments and national standards laboratories worldwide. Using highly stable optical materials such as Zerodur®, and benefiting from a thermally stable production environment, Optical Surfaces routinely achieves surface accuracies of better than ʎ/20 peak to valley and surface roughness of less than 10 A rms on optical flats up to 600mm in diameter.
Open in Who Shared Issue with article?

Versant Diagnostics Expands Collaboration With Leica Biosystems As PRW Laboratories Becomes First To Deploy Aperio GT Elite Solution

| Laboratory Network
Milestone deployment reflects growing demand for high-throughput, AI-enabled digital pathology workflows Leica Biosystems, a Danaher company and a global leader in end-to-end anatomic and digital pathology solutions, and Versant Diagnostics, an independent physician services company actively engaged in next-generation digital pathology, announce an expanded collaboration to advance digital pathology adoption.
Open in Who Shared Issue with article?

Legacy Receives New York State CLEP Approval For Two Laboratory-Developed Tests: Semen Analysis And DNA Fragmentation

| Laboratory Network
Legacy clears New York's stringent pre-market review of laboratory-developed tests for both of its core andrology assays, semen analysis and DNA fragmentation analysis.
Open in Who Shared View Duplicates (157) Issue with article?

Quest Diagnostics Receives New York State Approval For Haystack MRD®, Broadening Patient Access To ctDNA Minimal Residual Disease Testing

| Laboratory Network
Achieving the rigorous laboratory standard broadens access for providers and patients in New York; applies to use of Haystack MRD for patients with solid tumor cancers Secaucus, NJ /PRNewswire/ - Quest Diagnostics® (NYSE: DGX), a leading provider of diagnostic information services, today announced that the New York State Department of Health's (NYSDOH) Clinical Laboratory Evaluation Program (CLEP) has approved the company's Haystack MRD® test, a circulating tumor DNA (ctDNA) liquid biopsy...
Open in Who Shared View Duplicates (75) Issue with article?

VERAXA Biotech Expands R&D Hub In Heidelberg As Innovative BiTAC™-TCE And ADC Programs Advance Towards Clinical Development

| Laboratory Network
Greater than 60% increase in laboratory space will strengthen R&D capabilities, facilitate acceleration toward clinical development, and increase ability to tap into Heidelberg’s world-class medical oncology environment Zurich, Switzerland (GLOBE NEWSWIRE) - VERAXA Biotech AG (NASDAQ: VRXA; “VERAXA”), an emerging leader in designing novel cancer therapies, today announced that the Company has moved into additional laboratory space at its existing R&D site in Heidelberg, Germany, based on a...
Open in Who Shared Issue with article?

ALZpath Signs Global Licensing Agreement With Abbott To Advance Blood-Based Alzheimer's Disease Testing

| Laboratory Network
ALZpath Strengthens Market Leadership with Abbott Agreement to Help Enable Early Alzheimer's Diagnosis at Global Scale Carlsbad, CA /PRNewswire/ - ALZpath Inc., the leader in blood test-based diagnostic solutions for Alzheimer's disease, today announced a licensing agreement with Abbott (NYSE: ABT), a global healthcare leader, to incorporate ALZpath's proprietary phosphorylated Tau 217 (pTau217) antibody into the development of an in vitro diagnostic (IVD) test for Alzheimer's disease.
Open in Who Shared View Duplicates (47) Issue with article?